Gauri Shishodia

797 total citations
18 papers, 661 citations indexed

About

Gauri Shishodia is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Gauri Shishodia has authored 18 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Gauri Shishodia's work include Cervical Cancer and HPV Research (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and MicroRNA in disease regulation (4 papers). Gauri Shishodia is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and MicroRNA in disease regulation (4 papers). Gauri Shishodia collaborates with scholars based in United States and India. Gauri Shishodia's co-authors include Hari K. Koul, Sweaty Koul, Alok C. Bharti, Bhudev C. Das, Sankaralingam Saikolappan, Binod Kumar, Shirish Shukla, Sutapa Mahata, Seemi Farhat Basir and Suresh Bhambhani and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Gauri Shishodia

17 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gauri Shishodia United States 10 315 256 169 159 78 18 661
Dong‐Sheng Huang China 13 317 1.0× 140 0.5× 139 0.8× 56 0.4× 66 0.8× 31 671
Aditya Parekh India 12 418 1.3× 205 0.8× 69 0.4× 60 0.4× 58 0.7× 21 738
Hui Li Ang Singapore 12 500 1.6× 245 1.0× 142 0.8× 50 0.3× 51 0.7× 13 862
Alexandra Daks Russia 18 552 1.8× 220 0.9× 216 1.3× 48 0.3× 90 1.2× 55 926
Sian Chen China 11 519 1.6× 331 1.3× 104 0.6× 64 0.4× 55 0.7× 18 801
Rehan M. Villani Australia 9 436 1.4× 130 0.5× 125 0.7× 43 0.3× 62 0.8× 19 787
Qian Zhong China 16 420 1.3× 154 0.6× 209 1.2× 51 0.3× 60 0.8× 41 862
Xu He China 19 358 1.1× 281 1.1× 213 1.3× 74 0.5× 79 1.0× 49 912
Dazhi Cen United States 4 223 0.7× 91 0.4× 112 0.7× 82 0.5× 50 0.6× 7 474
Yunduo Liu China 16 385 1.2× 197 0.8× 156 0.9× 35 0.2× 64 0.8× 46 715

Countries citing papers authored by Gauri Shishodia

Since Specialization
Citations

This map shows the geographic impact of Gauri Shishodia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gauri Shishodia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gauri Shishodia more than expected).

Fields of papers citing papers by Gauri Shishodia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gauri Shishodia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gauri Shishodia. The network helps show where Gauri Shishodia may publish in the future.

Co-authorship network of co-authors of Gauri Shishodia

This figure shows the co-authorship network connecting the top 25 collaborators of Gauri Shishodia. A scholar is included among the top collaborators of Gauri Shishodia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gauri Shishodia. Gauri Shishodia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shishodia, Gauri, et al.. (2024). Long non-coding RNAs: A trained immunity perspective. 3(2). 2791–2791. 1 indexed citations
2.
3.
Shishodia, Gauri, et al.. (2021). 4NQO enhances differential activation of DNA repair proteins in HPV positive and HPV negative HNSCC cells. Oral Oncology. 122. 105578–105578. 2 indexed citations
4.
Shishodia, Gauri, et al.. (2021). Pancreatic cancer: genetics, disease progression, therapeutic resistance and treatment strategies. Journal of Cancer Metastasis and Treatment. 7. 6 indexed citations
5.
Saikolappan, Sankaralingam, Binod Kumar, Gauri Shishodia, Sweaty Koul, & Hari K. Koul. (2019). Reactive oxygen species and cancer: A complex interaction. Cancer Letters. 452. 132–143. 187 indexed citations
6.
Shukla, Shirish, Gauri Shishodia, Sutapa Mahata, et al.. (2019). Level of phospho-STAT3 (Tyr705) correlates with copy number and physical state of human papillomavirus 16 genome in cervical precancer and cancer lesions. PLoS ONE. 14(9). e0222089–e0222089. 17 indexed citations
7.
Shishodia, Gauri, Sweaty Koul, & Hari K. Koul. (2019). Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling. The Prostate. 79(15). 1739–1751. 18 indexed citations
8.
Shishodia, Gauri, Sweaty Koul, Qin Dong, & Hari K. Koul. (2018). Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis. Molecular Cancer Therapeutics. 17(6). 1217–1228. 25 indexed citations
9.
Shishodia, Gauri, P. Srinivasan, Sweaty Koul, & Hari K. Koul. (2018). Abstract 1079: PCDH7 is overexpressed in advanced prostate cancer and modulates aggressive phenotype in prostate cancer cells. Cancer Research. 78(13_Supplement). 1079–1079.
10.
Shishodia, Gauri, Sweaty Koul, Qin Dong, & Hari K. Koul. (2017). Abstract 2837: Differential expression of Protocadherin-7 (PCDH7) in prostate cancer (PCa) cells: a direct association between PCDH7 and castrate resistant PCa. Cancer Research. 77(13_Supplement). 2837–2837. 1 indexed citations
11.
Shishodia, Gauri, Sweaty Koul, Qin Dong, Sergey V. Slepenkov, & Hari K. Koul. (2016). Abstract 253: Tetrandrine promotes prostate cancer cell apoptosis in part by up-regulation of death receptors. Cancer Research. 76(14_Supplement). 253–253. 2 indexed citations
12.
Shishodia, Gauri, Shirish Shukla, Yogesh Srivastava, et al.. (2015). Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis. Molecular Cancer. 14(1). 116–116. 78 indexed citations
13.
Shukla, Shirish, Sutapa Mahata, Gauri Shishodia, et al.. (2014). Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer. SHILAP Revista de lepidopterología. 5 indexed citations
14.
Shukla, Shirish, Sutapa Mahata, Gauri Shishodia, et al.. (2014). Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer.. PubMed. 139(4). 531–43. 45 indexed citations
15.
Shishodia, Gauri, G. S. Verma, Yogesh Srivastava, et al.. (2014). Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein. BMC Cancer. 14(1). 996–996. 58 indexed citations
16.
Shukla, Shirish, Sutapa Mahata, Gauri Shishodia, et al.. (2013). Functional Regulatory Role of STAT3 in HPV16-Mediated Cervical Carcinogenesis. PLoS ONE. 8(7). e67849–e67849. 64 indexed citations
17.
18.
Shukla, Shirish, Gauri Shishodia, Sutapa Mahata, et al.. (2010). Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Molecular Cancer. 9(1). 282–282. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026